December issue highlights, including mammography screening for younger women with familial breast cancer.

November issue highlights, including an large-scale HPV genotype analysis with implications for cervical-cancer vaccine development, and the potential for discontinuation of imatinib treatment for people with chronic myeloid leukaemia.

Includes author interview about a trial comparing sentinal-lymph-node biopsy with axillary-lymph-node dissection in breast cancer treatment.

September issue highlights, including discussion of a possible association between hepatitis B infection and non-Hodgkin lymphoma in a Korean population.

August issue highlights, including bevacizumab for NSCLC, and cancer issues among people with mental illness.

Roy Herbst discusses the Zodiac trial, a phase 3 study assessing the efficacy of vandetanib for treating advanced non-small-cell lung cancer.

Emma Grainger discusses erlotinib as maintenance treatment for lung cancer, and IGF1 and risk of breast cancer.

The role of zoledronic acid with chemotherapy for early breast cancer and other issue highlights are discussed.

April issue highlights, including a genome-wide association study of lung cancer for never smokers.

March issue highlights, including hypofractionated radiotherapy for early breast cancer.